Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 6, 2006JNCI Journal of the National Cancer Institute

Cyclooxygenase-2 (COX-2)–Independent Anticarcinogenic Effects of Selective COX-2 Inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

SGSabine GröschGoethe University FrankfurtTMThorsten J. MaierGoethe University FrankfurtSSSusanne SchiffmannGoethe University Frankfurt

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Grösch et al. (2006) studied this question.

synapsesocial.com/papers/69ddde317ed287395e558409https://doi.org/10.1093/jnci/djj206
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Increased endothelial uptake of paclitaxel as a potential mechanism for its antiangiogenic effects: Potentiation by Cox‐2 inhibition2004 · 79 citations
  2. 2Expression of Carbonic Anhydrase IX (CA IX), a Hypoxia-Related Protein, Rather Than Vascular-Endothelial Growth Factor (VEGF), a Pro-Angiogenic Factor, Correlates With an Extremely Poor Prognosis in Esophageal and Gastric Adenocarcinomas2006 · 124 citations
  3. 3Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical Issues2002 · 1,439 citations
  4. 4COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells2002 · 163 citations